Cargando…
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
BACKGROUND: Extensive genetic diversity in vaccine antigens may contribute to the lack of efficacy of blood stage malaria vaccines. Apical membrane antigen-1 (AMA1) is a leading blood stage malaria vaccine candidate with extreme diversity, potentially limiting its efficacy against infection and dise...
Autores principales: | Ouattara, Amed, Mu, Jianbing, Takala-Harrison, Shannon, Saye, Renion, Sagara, Issaka, Dicko, Alassane, Niangaly, Amadou, Duan, Junhui, Ellis, Ruth D, Miller, Louis H, Su, Xin-zhuan, Plowe, Christopher V, Doumbo, Ogobara K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908102/ https://www.ncbi.nlm.nih.gov/pubmed/20565971 http://dx.doi.org/10.1186/1475-2875-9-175 |
Ejemplares similares
-
Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali
por: Ouattara, Amed, et al.
Publicado: (2011) -
Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
por: Gaudart, Jean, et al.
Publicado: (2006) -
Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
por: Miura, Kazutoyo, et al.
Publicado: (2011) -
Differential Incidence of Malaria in Neighboring Villages in a High-Transmission Setting of Southern Mali
por: Fofana, Bakary, et al.
Publicado: (2022) -
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)